InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
6
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Stein Jeffrey, Chief Executive Officer. Officer active across 3 companies, notably Cidara Therapeutics, Inc.. Cumulatively, 18 disclosures have been recorded. Split: 6 buys · 1 sell. Total volume traded: €1.7m. History available since 18 August 2021. The latest transaction was filed on 2 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Stein Jeffrey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
50,000 shares@ US$32.9578100.0% of flowCommon StockSEC:0001610717-26-000078:0
Canonical exit: 31 May 2026 (T+90)
270 sharesCommon StockSEC:0001478831-26-000004:0
5,763 shares@ US$221.5058.2% of flowCommon StockSEC:0001478831-26-000005:0
33,072 shares0Common StockSEC:0001478831-25-000004:0
2,285 shares@ US$219.6055.0% of flowCommon StockSEC:0001610618-25-000104:0
8,000 shares@ US$13.2120.2% of flowCommon StockSEC:0001628280-24-027720:0
Canonical exit: 5 Sept 2024 (T+90)
56,692 shares@ US$0.697.4% of flowCommon StockSEC:0001610618-24-000017:0
48,625 sharesCommon StockSEC:0000899243-23-019362:0
50,000 shares@ US$0.95779.1% of flowCommon StockSEC:0001610618-23-000081:0
Canonical exit: 6 Nov 2023 (T+90)
271,750 shares0Common StockSEC:0001610618-23-000034:0
50,000 shares@ US$1.037110.0% of flowCommon StockSEC:0001610618-23-000026:0
Canonical exit: 25 Jun 2023 (T+90)
7,000 shares@ US$1.90100.0% of flowCommon StockSEC:0000904454-23-000178:0
20,000 shares0Common StockSEC:0000904454-23-000111:0
165,000 shares0Common StockSEC:0001610618-22-000023:0
20,000 shares0Common StockSEC:0000904454-22-000173:0
20,000 shares0Common StockSEC:0001209191-22-002603:0
50,000 shares@ US$1.590627.1% of flowCommon StockSEC:0001610618-21-000108:0
Canonical exit: 10 Feb 2022 (T+90)
40,000 shares@ US$1.72213.1% of flowCommon StockSEC:0001209191-21-052546:0
Canonical exit: 16 Nov 2021 (T+90)
18 of 18 declarations
About Stein Jeffrey
Jeffrey Stein serves as Chief Executive Officer and Board Member at Cidara Therapeutics, Inc. and Paratek Pharmaceuticals, Inc. He oversees the strategic and operational direction of these companies, ensuring that growth objectives are met. Jeffrey has a strong background in the pharmaceutical sector, enabling him to effectively lead his teams towards operational excellence. His commitment to innovation and sustainability is central to his mission.
